HMS
MIRM icon

Hanseatic Management Services’s Mirum Pharmaceuticals MIRM Stock Holding History

Hanseatic Management Services’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$6.53K Hold
158
– – 0.01% 102
2024
Q3 		$6.16K Buy
+158
New +$6.3K 0.01% 104

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hanseatic Management Services's MIRM Position: Q4 2024 in Review

Hanseatic Management Services held its Mirum Pharmaceuticals (MIRM) position steady in Q4 2024 at 158 shares worth $6.53K. The position accounts for 0.01% of the portfolio, ranked #102.

Hanseatic Management Services first reported a position in MIRM in Q3 2024 and has held it in 2 quarters since. 205 funds tracked by Wall St. Rank hold MIRM as of Q4 2024.

  • Hanseatic Management Services held 158 shares of Mirum Pharmaceuticals worth $6.53K as of Q4 2024.
  • Hanseatic Management Services left its Mirum Pharmaceuticals share count unchanged in Q4 2024.
  • Mirum Pharmaceuticals made up 0.01% of Hanseatic Management Services's portfolio in Q4 2024, its #102 holding.
  • Hanseatic Management Services first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 2 quarters since.
  • 205 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2024.

Based on Hanseatic Management Services's 13F filing for Q4 2024, filed 15 Jan 2025.